Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Monogram Orthopaedics Inc ( (MGRM) ) just unveiled an update.
Monogram Technologies announced that following a recent meeting with the FDA, it believes it has addressed the agency’s concerns regarding its 510(k) submission for the mBôs TKA System, potentially avoiding the need for clinical data. The company anticipates providing a comprehensive response to the FDA’s Additional Information Request in Q1 2025, marking a significant step towards FDA clearance, which would advance its mission in orthopedic medicine.
More about Monogram Orthopaedics Inc
Monogram Technologies Inc. is an AI-driven robotics company focused on orthopedic surgery, aiming to improve human health through patient-optimized orthopedic implants. Utilizing a combination of 3D printing, machine vision, AI, and robotics, the company develops robotic surgical equipment, orthopedic implants, and related software.
YTD Price Performance: -19.77%
Average Trading Volume: 126,100
Technical Sentiment Consensus Rating: Sell
Learn more about MGRM stock on TipRanks’ Stock Analysis page.
